STAT+: Pharmalittle: Moderna’s Covid-19 vaccine rolls out across the U.S.; FDA rejects Novartis cholesterol drug
Good morning, one and all. Damian Garde here, filling in for Ed Silverman on this truncated week before that big holiday. Perhaps you’ve got a few days off on the horizon, or maybe you’re working straight through the shortened days of December. Either way, here’s hoping the comforts of home haven’t lost all their charm over these many months spent indoors. In the meantime, here, as always, are some tidbits to get your day started. …
Moderna’s (MRNA) Covid-19 vaccine got authorization from the Food and Drug Administration for emergency use, a week after a vaccine from Pfizer (PFE) and BioNTech (BNTX) received the same designation, STAT tells us. The vaccine is now rolling out across the U.S., and Moderna expects to ship about 20 million doses before the end of the year, enough to vaccinate 10 million people.
Continue to STAT+ to read the full story…
